Midday Gainers From November 17: Celldex Therapeutics, Amicus Therapeutics, Baker Hughes, Allergan

By: via Benzinga
Celldex Therapeutics, Inc.(NASDAQ: CLDX) +33% - Late Friday, the company announced interim results of its Phase 2 ReACT study ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.